These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 16953230

  • 1. A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth.
    Rasola A, Fassetta M, De Bacco F, D'Alessandro L, Gramaglia D, Di Renzo MF, Comoglio PM.
    Oncogene; 2007 Feb 15; 26(7):1078-87. PubMed ID: 16953230
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
    Murai M, Shen X, Huang L, Carpenter WM, Lin CS, Silverman S, Regezi J, Kramer RH.
    Int J Oncol; 2004 Oct 15; 25(4):831-40. PubMed ID: 15375530
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
    Ye M, Hu D, Tu L, Zhou X, Lu F, Wen B, Wu W, Lin Y, Zhou Z, Qu J.
    Invest Ophthalmol Vis Sci; 2008 Feb 15; 49(2):497-504. PubMed ID: 18234991
    [Abstract] [Full Text] [Related]

  • 6. Hepatocyte growth factor installs a survival platform for colorectal cancer cell invasive growth and overcomes p38 MAPK-mediated apoptosis.
    Fassetta M, D'Alessandro L, Coltella N, Di Renzo MF, Rasola A.
    Cell Signal; 2006 Nov 15; 18(11):1967-76. PubMed ID: 16677802
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.
    Kuroda T, Rabkin SD, Martuza RL.
    Cancer Res; 2006 Oct 15; 66(20):10127-35. PubMed ID: 17047077
    [Abstract] [Full Text] [Related]

  • 9. Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice.
    Apte U, Zeng G, Muller P, Tan X, Micsenyi A, Cieply B, Dai C, Liu Y, Kaestner KH, Monga SP.
    Hepatology; 2006 Oct 15; 44(4):992-1002. PubMed ID: 17006939
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F, Engst S, Yamaguchi K, Yu P, Won KA, Mock L, Lou T, Tan J, Li C, Tam D, Lougheed J, Yakes FM, Bentzien F, Xu W, Zaks T, Wooster R, Greshock J, Joly AH.
    Cancer Res; 2009 Oct 15; 69(20):8009-16. PubMed ID: 19808973
    [Abstract] [Full Text] [Related]

  • 11. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
    Matsushita A, Götze T, Korc M.
    Cancer Res; 2007 Nov 01; 67(21):10309-16. PubMed ID: 17974973
    [Abstract] [Full Text] [Related]

  • 12. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway.
    Dvory-Sobol H, Sagiv E, Liberman E, Kazanov D, Arber N.
    Cancer; 2007 Jan 15; 109(2):188-97. PubMed ID: 17149756
    [Abstract] [Full Text] [Related]

  • 13. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.
    Gastroenterology; 2009 Jul 15; 137(1):165-75. PubMed ID: 19328798
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2.
    Calviello G, Resci F, Serini S, Piccioni E, Toesca A, Boninsegna A, Monego G, Ranelletti FO, Palozza P.
    Carcinogenesis; 2007 Jun 15; 28(6):1202-9. PubMed ID: 17183061
    [Abstract] [Full Text] [Related]

  • 16. beta-Catenin and actin reorganization in HGF/SF response of ST14A cells.
    Soldati C, Biagioni S, Poiana G, Augusti-Tocco G.
    J Neurosci Res; 2008 Apr 15; 86(5):1044-52. PubMed ID: 17975841
    [Abstract] [Full Text] [Related]

  • 17. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
    Xu H, Washington S, Verderame MF, Manni A.
    Breast Cancer Res Treat; 2008 Nov 15; 112(2):255-61. PubMed ID: 18097746
    [Abstract] [Full Text] [Related]

  • 18. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ, Chen WK, Wang CJ, Lin WL, Tseng TH.
    Toxicol Appl Pharmacol; 2008 Jan 15; 226(2):178-91. PubMed ID: 17961621
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
    Organ SL, Tong J, Taylor P, St-Germain JR, Navab R, Moran MF, Tsao MS.
    J Proteome Res; 2011 Jul 01; 10(7):3200-11. PubMed ID: 21609022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.